{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:19:12Z","timestamp":1790882352030,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1093\/carcin\/23.3.463","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:42:52Z","timestamp":1027723372000},"page":"463-467","source":"Crossref","is-referenced-by-count":22,"title":["Effects of genetic background on prostate and taste bud carcinogenesis due to SV40 T antigen expression under probasin gene promoter control"],"prefix":"10.1093","volume":"23","author":[{"given":"Makoto","family":"Asamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hokaiwado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Man","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2002,3]]},"reference":[{"key":"key\n\t\t\t\t20170725014830_R1","doi-asserted-by":"crossref","unstructured":"Parker,S.L., Davis,K.J., Wingo,P.A., Ries,L.A. and Heath,C.W., Jr. (1998) Cancer statistics by race and ethnicity. CA Cancer J. Clin., 48, 31\u201348.","DOI":"10.3322\/canjclin.48.1.31"},{"key":"key\n\t\t\t\t20170725014830_R2","doi-asserted-by":"crossref","unstructured":"Robbins,A.S., Whittemore,A.S. and Van Den Eeden,S.K. (1998) Race, prostate cancer survival, and membership in a large health maintenance organization. J. Natl Cancer Inst., 90, 986\u2013990.","DOI":"10.1093\/jnci\/90.13.986"},{"key":"key\n\t\t\t\t20170725014830_R3","doi-asserted-by":"crossref","unstructured":"Kalapurakal,J.A., Jacob,A.N., Kim,P.Y., Najjar,D.D., Hsieh,Y.C., Ginsberg,P., Daskal,I., Asbell,S.O. and Kandpal,R.P. (1999) Racial differences in prostate cancer related to loss of heterozygosity on chromosome 8p12\u201323. Int J. Radiat. Oncol. Biol. Phys., 45, 835\u2013840.","DOI":"10.1016\/S0360-3016(99)00283-7"},{"key":"key\n\t\t\t\t20170725014830_R4","unstructured":"Cooney,K.A. (1998) Hereditary prostate cancer in African\u2013American families. Semin. Urol. Oncol., 16, 202\u2013206."},{"key":"key\n\t\t\t\t20170725014830_R5","doi-asserted-by":"crossref","unstructured":"Narod,S. (1999) Genetic epidemiology of prostate cancer. Biochim. Biophys. Acta, 1423, F1\u201313.","DOI":"10.1016\/S0304-419X(98)00030-4"},{"key":"key\n\t\t\t\t20170725014830_R6","doi-asserted-by":"crossref","unstructured":"Ekman,P. (1999) Genetic and environmental factors in prostate cancer genesis: identifying high-risk cohorts. Eur. Urol., 35, 362\u2013369.","DOI":"10.1159\/000019910"},{"key":"key\n\t\t\t\t20170725014830_R7","doi-asserted-by":"crossref","unstructured":"Sasaki,N., Hayashizaki,Y., Muramatsu,M. et al. (1994) The gene responsible for LEC hepatitis, located on rat chromosome 16, is the homolog to the human Wilson disease gene. Biochem. Biophys. Res. Commun., 202, 512\u2013518.","DOI":"10.1006\/bbrc.1994.1958"},{"key":"key\n\t\t\t\t20170725014830_R8","doi-asserted-by":"crossref","unstructured":"Pascale,R.M., Simile,M.M., DeMiglio,M.R., Muroni,M.R., Gaspa, L., Dragani,T.A. and Feo,F. (1996) The BN rat strain carries dominant hepatocarcinogen resistance loci. Carcinogenesis, 17, 1765\u20131768.","DOI":"10.1093\/carcin\/17.8.1765"},{"key":"key\n\t\t\t\t20170725014830_R9","doi-asserted-by":"crossref","unstructured":"Kamoto,T., Mori,S., Murai,T., Yamada,Y., Makino,S., Yoshida,O. and Hiai,H. (1997) Quantitative trait loci associated with promoting effects of sodium L-ascorbate on two-stage bladder carcinogenesis in rats. Jpn. J. Cancer Res., 88, 633\u2013638.","DOI":"10.1111\/j.1349-7006.1997.tb00430.x"},{"key":"key\n\t\t\t\t20170725014830_R10","doi-asserted-by":"crossref","unstructured":"Yamada,S., Shima,H., Toyota,M. et al. (1998) Linkage mapping of the Bra, Brb and Brg genes for rat protein phosphatase 2A 55 kDa B-regulatory subunit isotypes. Jpn. J. Cancer Res., 89, 1014\u20131019.","DOI":"10.1111\/j.1349-7006.1998.tb00490.x"},{"key":"key\n\t\t\t\t20170725014830_R11","doi-asserted-by":"crossref","unstructured":"Oyabu,A., Higo,K., Ye,C., Amo,H. et al. (1999) Genetic mapping of the thymoma susceptible locus, Tsr1, in BUF\/Mna rats. J. Natl Cancer Inst., 91, 279\u2013282.","DOI":"10.1093\/jnci\/91.3.279"},{"key":"key\n\t\t\t\t20170725014830_R12","doi-asserted-by":"crossref","unstructured":"Kitada,K., Voigt,B., Kondo,Y. and Serikawa,T. (2000) An integrated rat genome map based on genetic and cytogenetic data. Exp. Anim., 49, 119\u2013126.","DOI":"10.1538\/expanim.49.119"},{"key":"key\n\t\t\t\t20170725014830_R13","doi-asserted-by":"crossref","unstructured":"Yoshida,Y., Ushijima,T., Yamashita,S., Imai,K., Sugimura,T. and Nagao,M. (1999) Development of the arbitrarily primed-representational difference analysis method and chromosomal mapping of isolated high throughput rat genetic markers. Proc. Natl Acad. Sci. USA, 96, 610\u2013615.","DOI":"10.1073\/pnas.96.2.610"},{"key":"key\n\t\t\t\t20170725014830_R14","doi-asserted-by":"crossref","unstructured":"Sharma,P. and Schreiber-Agus,N. (1999) Mouse models of prostate cancer. Oncogene, 18, 5349\u20135355.","DOI":"10.1038\/sj.onc.1203037"},{"key":"key\n\t\t\t\t20170725014830_R15","doi-asserted-by":"crossref","unstructured":"Shirai,T., Takahashi,S., Cui,L., Futakuchi,M., Kato,K., Tamano,S. and Imaida,K. (2000) Experimental prostate carcinogenesis \u2013 rodent models. Mutat Res., 462, 219\u2013226.","DOI":"10.1016\/S1383-5742(00)00039-9"},{"key":"key\n\t\t\t\t20170725014830_R16","doi-asserted-by":"crossref","unstructured":"Lucia,M.S., Bostwick,D.G., Bosland,M. et al. (1998) Workgroup I: Rodent models of prostate cancer. Prostate, 36, 49\u201355.","DOI":"10.1002\/(SICI)1097-0045(19980615)36:1<49::AID-PROS9>3.0.CO;2-6"},{"key":"key\n\t\t\t\t20170725014830_R17","doi-asserted-by":"crossref","unstructured":"Shirai,T., Iwasaki,S., Masui,T., Mori,T., Kato,T. and Ito,N. (1993) Enhancing effect of cadmium on rat ventral prostate carcinogenesis induced by 3,2\u2032-dimethyl-4-aminobiphenyl. Jpn. J. Cancer Res., 84, 1023\u20131030.","DOI":"10.1111\/j.1349-7006.1993.tb02796.x"},{"key":"key\n\t\t\t\t20170725014830_R18","doi-asserted-by":"crossref","unstructured":"Shirai,T., Imaida,K., Masui,T., Iwasaki,S., Mori,T., Kato,T. and Ito,N. (1994) Effects of testosterone, dihydrotestosterone and estrogen on 3,2\u2032-dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis. Int. J. Cancer, 57, 224\u2013228.","DOI":"10.1002\/ijc.2910570216"},{"key":"key\n\t\t\t\t20170725014830_R19","doi-asserted-by":"crossref","unstructured":"Shirai,T., Sano,M., Imaida,K., Takahashi,S., Mori,T. and Ito,N. (1994) Duration dependent induction of invasive prostatic carcinomas with pharmacological dose of testosterone propionate in rats pretreated with 3,2\u2032-dimethyl-4-aminobiphenyl and development of androgen-independent carcinomas after castration. Cancer Lett., 83, 11\u2013116.","DOI":"10.1016\/0304-3835(94)90306-9"},{"key":"key\n\t\t\t\t20170725014830_R20","doi-asserted-by":"crossref","unstructured":"Shirai,T., Tamano,S., Sano,M., Imaida,K., Hagiwara,A., Futakuchi,M., Takahashi,S. and Hirose,M. (1995) Site-specific effects of testosterone propionate on the prostate of rat pretreated with 3,2\u2032-dimethyl-4-aminobiphenyl: dose-dependent induction of invasive carcinomas. Jpn. J. Cancer Res., 86, 645\u2013648.","DOI":"10.1111\/j.1349-7006.1995.tb02447.x"},{"key":"key\n\t\t\t\t20170725014830_R21","doi-asserted-by":"crossref","unstructured":"Kawabe,M., Shibata,M.A., Sano,M., Takesada,Y., Tamano,S., Ito,N. and Shirai,T. (1997) Decrease of prostaglandin E2 and 5-bromo-2\u2032-deoxyuridine labeling but not prostate tumor development by indomethacin treatment of rats given 3,2\u2032-dimethyl-4-aminobiphenyl and testosterone propionate. Jpn. J. Cancer Res., 88, 350\u2013355.","DOI":"10.1111\/j.1349-7006.1997.tb00388.x"},{"key":"key\n\t\t\t\t20170725014830_R22","doi-asserted-by":"crossref","unstructured":"Miyata,E., Kawabe,M., Sano,M., Takesada,Y., Takahashi,S. and Shirai,T. (1997) Effects of tamoxifen, an antiestrogen, on rat prostate carcinogenesis by 3,2\u2032-dimethyl-4-aminobiphenyl and testosterone do not support an estrogen role in testosterone promotion. Prostate, 31, 9\u201313.","DOI":"10.1002\/(SICI)1097-0045(19970401)31:1<9::AID-PROS2>3.0.CO;2-K"},{"key":"key\n\t\t\t\t20170725014830_R23","doi-asserted-by":"crossref","unstructured":"Cui,L., Mori,T., Takahashi,S., Imaida,K., Akagi,K., Yada,H., Yaono,M. and Shirai,T. (1998) Slight promotion effects of intermittent administration of testosterone propionate and\/or diethylstilbestrol on 3,2\u2032-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis. Cancer Lett., 122, 195\u2013199.","DOI":"10.1016\/S0304-3835(97)00390-X"},{"key":"key\n\t\t\t\t20170725014830_R24","doi-asserted-by":"crossref","unstructured":"Tsukamoto,S., Akaza,H., Onozawa,M., Shirai,T. and Ideyama,Y. (1998) A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats. Cancer, 82, 531\u2013537.","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<531::AID-CNCR15>3.0.CO;2-2"},{"key":"key\n\t\t\t\t20170725014830_R25","doi-asserted-by":"crossref","unstructured":"Condon,M.S., Kaplan,L.A., Crivello,J.F., Horton,L. and Bosland,M.C. (1999) Multiple pathways of prostate carcinogenesis analyzed by using cultured cells isolated from rats treated with N-methyl-N-nitrosourea and testosterone. Mol. Carcinog., 25, 179\u2013186.","DOI":"10.1002\/(SICI)1098-2744(199907)25:3<179::AID-MC4>3.3.CO;2-J"},{"key":"key\n\t\t\t\t20170725014830_R26","unstructured":"McCormick,D.L., Rao,K.V., Steele,V.E., Lubet,R.A., Kelloff,G.J. and Bosland,M.C. (1999) Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. Cancer Res., 59, 521\u2013524."},{"key":"key\n\t\t\t\t20170725014830_R27","unstructured":"Asamoto,M., Hokaiwado,N., Cho,Y.-M., Takahashi,S., Ikeda,Y., Imaida,K. and Shirai,T. (2001) Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res., 61, 4693\u20134700."},{"key":"key\n\t\t\t\t20170725014830_R28","doi-asserted-by":"crossref","unstructured":"Asamoto,M., Hokaiwado,N., Cho,Y.-M., Ikeda,Y., Takahashi,S. and Shirai,T. (2001) Metastasizing neuroblastomas from taste buds in rats transgenic for the simian virus 40 large T antigen under control of the probasin gene promoter. Toxicol. Pathol., 29, 363\u2013368.","DOI":"10.1080\/019262301316905327"},{"key":"key\n\t\t\t\t20170725014830_R29","unstructured":"Greenberg,N.M., DeMayo,F.J., Sheppard,P.C. et al. (1994) The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol., 8, 230\u2013239."},{"key":"key\n\t\t\t\t20170725014830_R30","doi-asserted-by":"crossref","unstructured":"Asamoto,M., Ochiya,T., Toriyama-Baba,H., Ota,T., Sekiya,T., Terada,M. and Tsuda,H. (2000) Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis. Carcinogenesis, 21, 243\u2013249.","DOI":"10.1093\/carcin\/21.2.243"},{"key":"key\n\t\t\t\t20170725014830_R31","doi-asserted-by":"crossref","unstructured":"Shirai,T., Nakamura,A., Fukushima,S., Yamamoto,A., Tada,M. and Ito,N. (1990) Different carcinogenic responses in a variety of organs, including the prostate, of five different rat strains given 3,2\u2032-dimethyl-4-aminobiphenyl. Carcinogenesis, 11, 793\u2013797.","DOI":"10.1093\/carcin\/11.5.793"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/23\/3\/463\/19254654\/230463.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T03:41:08Z","timestamp":1512704468000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/23.3.463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2002,3]]},"published-print":{"date-parts":[[2002,3]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/23.3.463","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}